AdaptHealth Corp. (AHCO)

NASDAQ: AHCO · Real-Time Price · USD

5.22

-0.47 (-8.26%)

At close: Aug 10, 2026, 4:00 PM EDT

5.38

+0.16 (3.07%)

Pre-market: Aug 11, 2026, 8:13 AM EDT

AdaptHealth Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,227	3,245	3,261	3,200	2,971	2,455
Revenue Growth	4.17%	-0.49%	1.90%	7.73%	21.02%	132.35%
Gross Profit	549.81	609.2	681.09	624.07	580.12	445.61
Operating Income	-143.86	90.87	263.73	-598.4	190.41	225.61
Net Income	-16.04	-70.79	90.42	-678.9	69.32	156.18
Earnings Per Share	-1.71	-0.52	0.61	-5.31	0.33	0.67
EPS Growth	-	-	-	-	-50.75%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Wellness At Home	571.14	583.14	646.2	633.86	625.59
Sleep Health	1,472	1,378	1,349	1,292	1,104
Respiratory Health	727.77	691.16	651.15	614.56	554.14
Diabetes Health	-	592.41	614.41	660.04	687.09
Total	3,363	3,245	3,261	3,200	2,971

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	43.29	106.14	151.25	77.13	46.27	149.63
Total Debt	2,065	1,903	2,130	2,295	2,329	2,371
Net Cash (Debt)	-2,022	-1,797	-1,979	-2,218	-2,283	-2,221
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-14.85	-13.29	-14.60	-16.50	-10.87	-16.69

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	583.27	601.77	541.84	480.67	373.87	275.68
Capital Expenditures	-485.59	-382.39	-306.06	-337.46	-391.42	-203.31
Free Cash Flow	97.68	219.38	235.78	143.2	-17.56	72.37
Free Cash Flow Growth	-57.75%	-6.96%	64.65%	-	-	-53.57%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	17.04%	18.77%	20.89%	19.50%	19.53%	18.15%
Operating Margin	-4.46%	2.80%	8.09%	-18.70%	6.41%	9.19%
Pretax Margin	-5.12%	-0.47%	4.17%	-22.62%	3.30%	7.78%
Profit Margin	-4.47%	-2.04%	2.91%	-21.09%	2.46%	6.44%
FCF Margin	3.03%	6.76%	7.23%	4.47%	-0.59%	2.95%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	15.61	-	58.24	36.51
Forward PE	-	11.60	9.91	9.86	15.29	15.36
P/FCF Ratio	7.13	6.02	5.32	6.75	-	45.24
PS Ratio	0.21	0.41	0.38	0.30	0.87	1.33